Efficacy End Points and Dose Analysis of Food and Drug Administration-Approved Novel Drugs in 2020
ABSTRACT: Background: During 2020, the Food and Drug Administration approved 53 novel drugs. Objective: Biomarkers, surrogate endpoints and dosing regimens used in early and pivotal clinical stages are evaluated. Methods: Information on various efficacy end points of 2020 Food and Drug Administratio...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |